Prognostic factors for hematologic cancers

Hematol Oncol Clin North Am. 2000 Aug;14(4):907-24, ix-x. doi: 10.1016/s0889-8588(05)70318-x.

Abstract

This article reviews the molecular biology of hematologic cancers and the current understanding of prognostic factors for these cancers. Specific molecular biomarkers that have potential as prognostic factors for various hematologic cancers are discussed. Quantitative and statistical methods of evaluating the usefulness of prognostic factors are presented.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor
  • Chromosome Aberrations
  • Evaluation Studies as Topic
  • Forecasting
  • Gene Expression Profiling
  • Genetic Predisposition to Disease
  • Hematologic Neoplasms / epidemiology
  • Hematologic Neoplasms / genetics
  • Hematologic Neoplasms / mortality*
  • Hodgkin Disease / genetics
  • Hodgkin Disease / mortality
  • Humans
  • Incidence
  • Leukemia / classification
  • Leukemia / genetics
  • Leukemia / mortality
  • Logistic Models
  • Lymphoma, Non-Hodgkin / genetics
  • Lymphoma, Non-Hodgkin / mortality
  • Morbidity / trends
  • Multiple Myeloma / genetics
  • Multiple Myeloma / mortality
  • Neoplasms, Second Primary / epidemiology
  • Neoplastic Syndromes, Hereditary / epidemiology
  • Oncogenes
  • Outcome Assessment, Health Care / methods
  • Outcome Assessment, Health Care / statistics & numerical data
  • Prognosis
  • Proportional Hazards Models
  • ROC Curve
  • Reproducibility of Results
  • Survival Analysis
  • Tumor Virus Infections / epidemiology

Substances

  • Biomarkers, Tumor